| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Animal Model |







From the Departments of Internal Medicine D,*
Physiological Chemistry and Pathobiochemistry,
and Arteriosclerosis Research,¶
University ofMünster, Münster, Germany; the Department of Cellular andMolecular Pathology,
German Cancer ResearchCenter, Heidelberg, Germany; the Department of Pathology, Anatomy, andCell Biology,||
Thomas Jefferson University, Philadelphia,Pennsylvania; and the Institute of MolecularBiology,
Slovak Academy of Sciences,Bratislava, Slovak Republic
Decorin, a small dermatan-sulfate proteoglycan, participates in extracellular matrix assembly and influences directly and indirectly cell behavior via interactions with signaling membrane receptors and transforming growth factor (TGF)-ß. We have therefore compared the development of tubulointerstitial kidney fibrosis in wild-type (WT) and decorin-/- mice in the model of unilateral ureteral obstruction. Without obstruction, kidneys from decorin-/- mice did not differ in any aspect from their WT counterparts. However, already 12 hours after obstruction decorin-/- animals showed lower levels of p27KIP1 and soon thereafter a more pronounced up-regulation and activation of initiator and effector caspases followed by enhanced apoptosis of tubular epithelial cells. Later, a higher increase of TGF-ß1 became apparent. After 7 days, there was an up to 15-fold transient up-regulation of the related proteoglycan biglycan, which was mainly caused by the appearance of biglycan-expressing mononuclear cells. Other small proteoglycans showed no similar response. Because of enhanced degradation of type I collagen, end-stage kidneys from decorin-/- animals were more atrophic than WT kidneys. These data suggest that decorin exerts beneficial effects on tubulointerstitial fibrosis, primarily by influencing the expression of a key cyclin-dependent kinase inhibitor and by limiting the degree of apoptosis, mononuclear cell infiltration, tubular atrophy, and expression of TGF-ß1.
This article has been cited by other articles:
![]() |
A. Nakorchevsky, J. A. Hewel, S. M. Kurian, T. S. Mondala, D. Campbell, S. R. Head, C. L. Marsh, J. R. Yates III, and D. R. Salomon Molecular Mechanisms of Chronic Kidney Transplant Rejection via Large-Scale Proteogenomic Analysis of Tissue Biopsies J. Am. Soc. Nephrol., February 1, 2010; 21(2): 362 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Babelova, K. Moreth, W. Tsalastra-Greul, J. Zeng-Brouwers, O. Eickelberg, M. F. Young, P. Bruckner, J. Pfeilschifter, R. M. Schaefer, H.-J. Grone, et al. Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors J. Biol. Chem., September 4, 2009; 284(36): 24035 - 24048. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Zoeller, W. Pimtong, H. Corby, S. Goldoni, A. E. Iozzo, R. T. Owens, S.-Y. Ho, and R. V. Iozzo A Central Role for Decorin during Vertebrate Convergent Extension J. Biol. Chem., April 24, 2009; 284(17): 11728 - 11737. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Atsawasuwan, Y. Mochida, M. Katafuchi, M. Kaku, K. S. K. Fong, K. Csiszar, and M. Yamauchi Lysyl Oxidase Binds Transforming Growth Factor-{beta} and Regulates Its Signaling via Amine Oxidase Activity J. Biol. Chem., December 5, 2008; 283(49): 34229 - 34240. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goldoni, D. G. Seidler, J. Heath, M. Fassan, R. Baffa, M. L. Thakur, R. T. Owens, D. J. McQuillan, and R. V. Iozzo An Antimetastatic Role for Decorin in Breast Cancer Am. J. Pathol., September 1, 2008; 173(3): 844 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer and R. V. Iozzo Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction J. Biol. Chem., August 1, 2008; 283(31): 21305 - 21309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. D'Antoni, C. Torregiani, P. Ferraro, M.-C. Michoud, B. Mazer, J. G. Martin, and M. S. Ludwig Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L764 - L771. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boor, K. Sebekova, T. Ostendorf, and J. Floege Treatment targets in renal fibrosis Nephrol. Dial. Transplant., December 1, 2007; 22(12): 3391 - 3407. [Full Text] [PDF] |
||||
![]() |
K. J. Williams, G. Qiu, H. K. Usui, S. R. Dunn, P. McCue, E. Bottinger, R. V. Iozzo, and K. Sharma Decorin Deficiency Enhances Progressive Nephropathy in Diabetic Mice Am. J. Pathol., November 1, 2007; 171(5): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, H. Fukasawa, K. Kitagawa, C. Uchida, T. Hattori, T. Isobe, T. Oda, T. Misaki, N. Ohashi, K. Nakayama, et al. Renal Damage in Obstructive Nephropathy Is Decreased in Skp2-Deficient Mice Am. J. Pathol., August 1, 2007; 171(2): 473 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, W. Tsalastra, A. Babelova, M. Baliova, J. Minnerup, L. Sorokin, H.-J. Grone, D. P. Reinhardt, J. Pfeilschifter, R. V. Iozzo, et al. Decorin-Mediated Regulation of Fibrillin-1 in the Kidney Involves the Insulin-Like Growth Factor-I Receptor and Mammalian Target of Rapamycin Am. J. Pathol., January 1, 2007; 170(1): 301 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Learn, P. E. Fecci, R. J. Schmittling, W. Xie, I. Karikari, D. A. Mitchell, G. E. Archer, Z. Wei, H. Dressman, and J. H. Sampson Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers Clin. Cancer Res., December 15, 2006; 12(24): 7306 - 7315. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wolf, J. Bohlender, T. Bondeva, T. Roger, F. Thaiss, and U. O. Wenzel Angiotensin II Upregulates Toll-Like Receptor 4 on Mesangial Cells J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1585 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hartner, L. Schaefer, M. Porst, N. Cordasic, A. Gabriel, B. Klanke, D. P. Reinhardt, and K. F. Hilgers Role of fibrillin-1 in hypertensive and diabetic glomerular disease Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1329 - F1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. D. Pecly, R. G. Goncalves, E. P. Rangel, C. M. Takiya, F. S. Taboada, C. A. Martinusso, M. S. G. Pavao, and M. Leite Jr Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-{beta}, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1212 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. L. Groeneveld, M. Oroszlan, R. T. Owens, M. C. Faber-Krol, A. C. Bakker, G. J. Arlaud, D. J. McQuillan, U. Kishore, M. R. Daha, and A. Roos Interactions of the Extracellular Matrix Proteoglycans Decorin and Biglycan with C1q and Collectins J. Immunol., October 1, 2005; 175(7): 4715 - 4723. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bi, C. H. Stuelten, T. Kilts, S. Wadhwa, R. V. Iozzo, P. G. Robey, X.-D. Chen, and M. F. Young Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells J. Biol. Chem., August 26, 2005; 280(34): 30481 - 30489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-F. Beck, G. Guder, L. Schaefer, M. Pleskova, A. Babelova, M. H. Behrens, D. Mihalik, M. Beck, R. M. Schaefer, and J. Pfeilschifter Nitric Oxide Upregulates Induction of PDGF Receptor-{alpha} Expression in Rat Renal Mesangial Cells and in Anti-Thy-1 Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1948 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Bhide, C. A. Laschinger, P. D. Arora, W. Lee, L. Hakkinen, H. Larjava, J. Sodek, and C. A. McCulloch Collagen Phagocytosis by Fibroblasts Is Regulated by Decorin J. Biol. Chem., June 17, 2005; 280(24): 23103 - 23113. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schonherr, C. Sunderkotter, R. V. Iozzo, and L. Schaefer Decorin, a Novel Player in the Insulin-like Growth Factor System J. Biol. Chem., April 22, 2005; 280(16): 15767 - 15772. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, D. Mihalik, A. Babelova, M. Krzyzankova, H.-J. Grone, R. V. Iozzo, M. F. Young, D. G. Seidler, G. Lin, D. P. Reinhardt, et al. Regulation of Fibrillin-1 by Biglycan and Decorin Is Important for Tissue Preservation in the Kidney During Pressure-Induced Injury Am. J. Pathol., August 1, 2004; 165(2): 383 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, K.-F. Beck, I. Raslik, S. Walpen, D. Mihalik, M. Micegova, K. Macakova, E. Schonherr, D. G. Seidler, G. Varga, et al. Biglycan, a Nitric Oxide-regulated Gene, Affects Adhesion, Growth, and Survival of Mesangial Cells J. Biol. Chem., July 3, 2003; 278(28): 26227 - 26237. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Exp Biol Med, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ameye and M. F. Young Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases Glycobiology, September 1, 2002; 12(9): 107R - 116R. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |